Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Introducing: QIAseq Pan-cancer Multimodal Panel for comprehensive genomic profiling of solid tumors and heme malignancies

A single day sample to sequencing workflow for simultaneous enrichment and profiling of 605 relevant DNA variant and RNA fusion biomarkers found across different cancers as well as assessment of TMB and MSI, from one sample input as low as 10ng

Explore the Targets

The 605 loci 1.44Mb Panel

• Targets relevant genes and RNA fusions implicated in pathogenesis of solid and heme malignancies

• Enables assessment of key immunotherapy biomarkers:

A Unique and Innovative Workflow

Powered by the innovative QIAseq Multimodal technology built with QIAGEN’s proprietary Single Primer Extension (SPE) technology at the core, profile DNA and RNA biomarkers with confidence while enabling time and cost efficiencies, enabling a truly comprehensive workflow for genomic profiling.

QIAseq Multimodal: Combined DNA and RNA library construction in a single day

The QIAseq Pan-cancer Multimodal Panel Advantage

Learn More

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine